NEUNEUREN PHARMACEUTICALS LIMITEDMarket sensitive

Growing royalty anchors Neuren first ever dividend program

Date and time
Announcement type
Financial Results

More from Health Care

More News

ARLCompany Update12 November 2026

Ardea Resources (ASX: ARL) Scandium Study Models US$510m NPV